All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-0120ZP1621 | Anti-SLC22A12 (DS3292AB) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | DS3292AB | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1622 | Anti-SLC22A12 (DS3292AB) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Rabbit | DS3292AB | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1623 | Anti-SLC22A12 (2B5) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse | 2B5 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1624 | Anti-SLC22A12 (2B5) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Mouse | 2B5 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1625 | Anti-SLC22A12 (CBXS-1315) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | CBXS-1315 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1626 | Anti-SLC22A12 (CBXS-1315) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Rabbit | CBXS-1315 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1627 | Anti-SLC22A12 (CBXS-4400) h(CD28-CD3ζ) CAR, pCDCAR1 | Rabbit | CBXS-4400 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T Cell | ||
CAR-0120ZP1628 | Anti-SLC22A12 (CBXS-4400) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Rabbit | CBXS-4400 | Rabbit | scFv-4-1BB-CD3ζ | Lentiviral vector | T Cell | ||
CAR-SB-LX0424 | Anti-SLC22A12 (DS3292AB) h(CD28-CD3ζ) CAR, pSBCAR1 | Human | DS3292AB | Rabbit | scFv-CD28-CD3ζ | Sleeping Beauty (SB) transposon | T cell | ||
XS-0622-ZP3239 | Anti-SLC22A12 h(VHH1-VHH2-CD28-CD3ζ) Biepitopic CAR, pCDCAR1 | Human | VHH1-VHH2-CD28-CD3ζ | Lentiviral vector | T Cell | ||||
XS-0622-ZP3411 | Anti-SLC22A12 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
XS-0822-YF810 | Anti-Human SLC22A12 (XW-810) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-810 | Rabbit | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF811 | Anti-Human SLC22A12 (XW-811) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-811 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF812 | Anti-Mouse SLC22A12 (XW-812) m(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-812 | Rat | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1730 | Anti-Human SLC22A12 (XW-810) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-810 | Rabbit | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1731 | Anti-Human SLC22A12 (XW-811) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-811 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1732 | Anti-Mouse SLC22A12 (XW-812) m(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-812 | Rat | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2650 | Anti-Human SLC22A12 (XW-810) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-810 | Rabbit | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2651 | Anti-Human SLC22A12 (XW-811) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-811 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2652 | Anti-Mouse SLC22A12 (XW-812) m(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Mouse | XW-812 | Rat | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION